Adam Wardrop (ISN)


British Columbia Athletic Commission have suspended Russian UFC flyweight contender Ali Bagautinov for the use of the banned substance erythropoietin (EPO).

Bagautinov was one of eight fighters selected for the drug test administered on June 2nd

The Commission released this statement:

Mr. Ali Bagautinov – one of the two flyweight title fighters was tested out of competition on June 2, 2014. Results received by this office from the June 2 tests on Mr. Bagautinov were positive for erythropoietin, or EPO, a substance banned by the World Anti-Doping Agency. These results were not available prior to the UFC 174 event due to lab processing times

Mr. Bagautinov lost his bid for the flyweight title to Demetrious Johnson. I have suspended Mr. Bagautinov’s licence to compete in British Columbia for a period of one year.”

This is the 2nd high-profile fighter, following Chael Sonnen, to test positive for banned substances in a short span of time. The UFC has been under increased pressure to enhance anti-doping policy and this will only serve to further the issue.

The UFC followed up the news with this statement.

UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO).  He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC.  The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes.  Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.

UFC President Dana White is expected to release a statement later today.